z-logo
Premium
Exploration of suitable pharmacodynamic parameters for acarbose bioequivalence evaluation: A series of clinical trials with branded acarbose
Author(s) -
Huang Jie,
Liu Wenyu,
Yu Jingjing,
Yang Jinbo,
Li Min,
Zou Chan,
Guo Chengxian,
Yang Xiaoyan,
Yang Shuang,
Xie Jinlian,
Huang Zhijun,
Chen Hui,
Pei Qi,
Yang Guoping
Publication year - 2020
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/bcp.14324
Subject(s) - acarbose , bioequivalence , crossover study , confidence interval , medicine , pharmacodynamics , geometric mean , food and drug administration , pharmacokinetics , pharmacology , endocrinology , mathematics , placebo , diabetes mellitus , statistics , alternative medicine , pathology
To determine deficiencies in the Food and Drug Administration (FDA)'s guidance for assessing acarbose bioequivalence (BE) and to explore optimal pharmacodynamic (PD) metrics for better evaluation of acarbose BE.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here